FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/01/039811 [Registered on: 28/01/2022] Trial Registered Prospectively
Last Modified On: 28/01/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To study the effect of ayurvedic syrup in kidney stone 
Scientific Title of Study   CLINICAL EFFICACY OF CHINCHAKSHAR IN THE MANAGEMENT OF MUTRASHMARI WITH SPECIAL REFERENCE TO UROLITHIASIS 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Suhas Vishvakant Vibhute 
Designation  PG Scholar  
Affiliation  Ayurved seva sangh ayurved mahavidyalaya 
Address  OPD No 6, Shalya tantra opd

Nashik
MAHARASHTRA
422203
India 
Phone  9604095250  
Fax    
Email  suhasvvibhute@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vinay Sonambekar 
Designation  Professor and Head 
Affiliation  Ayurved seva sangh ayurved mahavidyalaya 
Address  OPD No 6, Shalya tantra opd

Nashik
MAHARASHTRA
422203
India 
Phone  9822624890  
Fax    
Email  sonambekar.chinmay@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vinay Sonambekar 
Designation  Professor and Head 
Affiliation  Ayurved seva sangh ayurved mahavidyalaya 
Address  OPD No 6, Shalya tantra opd

Nashik
MAHARASHTRA
422203
India 
Phone  9822624890  
Fax    
Email  sonambekar.chinmay@gmail.com  
 
Source of Monetary or Material Support  
Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik  
 
Primary Sponsor  
Name  DR SUHAS VISHVAKANT VIBHUTE 
Address  AYURVED SEVA SANGHA ,AYURVED MAHAVIDYALAYA NASHIK  
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SUHAS VISHVAKANT VIBHUTE  AYURVED SEVA SANGHA ,AYURVED MAHAVIDYALAYA ,NASHIK  OPD NO 6,SHALYATANTRA
Nashik
MAHARASHTRA 
9604095250

suhasvvibhute@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical committee,Ayurved mahavidyalaya, Arogyashala rugnalaya ,Nashik  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N202||Calculus of kidney with calculus of ureter. Ayurveda Condition: MUTRAVAHASROTOVIKARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: CHINCHAKSHAR, Reference: RASATARANGINI, Route: Oral, Dosage Form: Kshara , Dose: 10(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: WATER), Additional Information: -
2Comparator ArmDrugOther than Classical(1) Medicine Name: CYSTONE, Reference: NA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: WATER), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients diagnosed as a case stone of KUB
Patient having calculi size in between 3-10 mm patient giving consent for participating in study
 
 
ExclusionCriteria 
Details  Patient having calculi size greater than 10 mm
Patient having chronic or acute kidney disorders
Patient having obstructive uropathy
Patient having Malignancy disorder of KUB
Patient is known case of hyperparathyroidism.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in renal colic pain
Reduction in size of calculi 
30 days 
 
Secondary Outcome  
Outcome  TimePoints 
COST EFFECTIVE and EASY TO PREPARE  30 days 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/02/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Diagnosed Calculus in KUB will be treated  with 2  Groups, group  A- Controlled Group DRUG– Tab.Cystone 2 Tab.(500mg) BD , Twice a day with water for  30 Days , and group B –TRIAL GROUP DRUG:-CHINCHAKSHAR  10ml BD Twice daily After meal with water for 30 Days and total no of patients will be  50 in each group, assessment criteria for study will be the Patients fulfilling diagnostic criteria and signs and symptoms of Mutrashmari.Patients those willing to participate in the study, Age between 20 to 60 yrs ,Both male and female,diagnosed patients of renal calculus,calculi size in between 3-10 mm and patient having calculi size greater than 10 mm,chronic or acute kidney disorders, obstructive uropathy, maligancy disorder of KUB will be excluded from the study.Patients will be taken for study from opd no 6 shalyatantra department .

 
Close